Skip to content
10-Q

Quarterly Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-14-000019

← back to feed
Filed
Aug 11, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 11, 2014 100 sh
Long Term Debt Q2 2014 · Jun 30, 2014 $1.91B
Long Term Debt Q2 2014 · Dec 31, 2013 $1.52B
Short Term Debt Q2 2014 · Jun 30, 2014 $13.09M
Short Term Debt Q2 2014 · Dec 31, 2013 $21.46M
Stockholders Equity Q2 2014 · Jun 30, 2014 $594.45M
Stockholders Equity Q2 2014 · Dec 31, 2013 $547.36M
Current Liabilities Q2 2014 · Jun 30, 2014 $242.76M
Current Liabilities Q2 2014 · Dec 31, 2013 $258.97M
Current Assets Q2 2014 · Jun 30, 2014 $554.64M
Current Assets Q2 2014 · Dec 31, 2013 $465.58M
Total Assets Q2 2014 · Jun 30, 2014 $3.07B
Total Assets Q2 2014 · Dec 31, 2013 $2.63B
Capex Q2 2014 · Jun 30, 2013 $8.6M
Operating Cash Flow Q2 2014 · Jun 30, 2013 $20.19M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $54.48M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $36.79M
Sga Expense Q2 2014 · Jun 30, 2013 $36.82M
Sga Expense Q2 2014 · Jun 30, 2013 $77.62M
Rd Expense Q2 2014 · Jun 30, 2013 $25.81M
Rd Expense Q2 2014 · Jun 30, 2013 $46.04M
Net Income Q2 2014 · Jun 30, 2013 −$21.79M
Net Income Q2 2014 · Jun 30, 2013 −$36.54M
Operating Income Q2 2014 · Jun 30, 2013 −$7.5M
Operating Income Q2 2014 · Jun 30, 2013 $1.11M
Gross Profit Q2 2014 · Jun 30, 2013 $58.9M
Gross Profit Q2 2014 · Jun 30, 2013 $130.34M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $174.77M
Cost Of Revenue Q2 2014 · Jun 30, 2013 $393.52M
Revenue Q2 2014 · Jun 30, 2013 $233.67M
Revenue Q2 2014 · Jun 30, 2013 $523.87M